9J09 image
Deposition Date 2024-08-02
Release Date 2025-06-04
Last Version Date 2025-07-23
Entry Detail
PDB ID:
9J09
Title:
Cryo-EM structure of the RdCas12n-sgRNA-DNA complex
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.95 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Transposase
Gene (Uniprot):HXO56_11955
Chain IDs:A
Chain Length:540
Number of Molecules:1
Biological Source:Rothia dentocariosa
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (40-MER)
Chain IDs:B (auth: C)
Chain Length:40
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Molecule:DNA (5'-D(P*GP*CP*TP*GP*TP*GP*AP*GP*AP*AP*AP*CP*CP*G)-3')
Chain IDs:C (auth: D)
Chain Length:14
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polyribonucleotide
Molecule:sgRNA
Chain IDs:D (auth: R)
Chain Length:214
Number of Molecules:1
Biological Source:Rothia dentocariosa
Ligand Molecules
Primary Citation
Mechanisms and engineering of a miniature type V-N CRISPR-Cas12 effector enzyme.
Nat Commun 16 5667 5667 (2025)
PMID: 40595633 DOI: 10.1038/s41467-025-61290-3

Abstact

Type V CRISPR-Cas12 systems are highly diverse in their functionality and molecular compositions, including miniature Cas12f1 and Cas12n genome editors that provide advantages for efficient in vivo therapeutic delivery due to their small size. In contrast to Cas12f1 nucleases that utilize a homodimer structure for DNA targeting and cleavage with a preference for T- or C-rich PAMs, Cas12n nucleases are likely monomeric proteins and uniquely recognize rare A-rich PAMs. However, the molecular mechanisms behind RNA-guided genome targeting and cleavage by Cas12n remain unclear. Here, we present the cryo-electron microscopy (cryo-EM) structure of Rothia dentocariosa Cas12n (RdCas12n) bound to a single guide RNA (sgRNA) and target DNA, illuminating the intricate molecular architecture of Cas12n and its sgRNA, as well as PAM recognition and nucleic-acid binding mechanisms. Through structural comparisons with other Cas12 nucleases and the ancestral precursor TnpB, we provide insights into the evolutionary significance of Cas12n in the progression from TnpB to various Cas12 nucleases. Additionally, we extensively modify the sgRNA and convert RdCas12n into an effective genome editor in human cells. Our findings enhance the understanding of the evolutionary mechanisms of type V CRISPR-Cas12 systems and offer a molecular foundation for engineering Cas12n genome editors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures